viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
uurimisrühmad - University of Buenos Aires, Faculty of Pharmacy and Biochemistry
University of Buenos Aires, Faculty of Pharmacy and Biochemistry
Buenos Aires
diegochiappetta@yahoo.com.ar
Viited
(4)
1
Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients.
Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli. (slucangi@ffyb.uba.ar)
Hosp Pharm -
2019
-
2
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus.
Estevez P, Boscolo O, Quiroga E, Penuto R.F, Buontempo F, Tripodi V, Lucangioli S. (slucangi@ffyb.uba.ar)
EJHP -
2016
- ; 23: 4: 213-218.
3
Suspensiones extratemporáneas de clobazam para uso pediátrico preparadas a partir de tabletas disponibles comercialmente y fármaco puro.
Buontempo F, Moretton M.A, E. Quiroga y D. A. Chiappetta. (diegochiappetta@yahoo.com.ar)
Farm Hosp -
2013
- ; 37, 21: 103-110.
4
Carvedilol stability in paediatric oral liquid formulations.
Buontempo F, Bernabeu E, Glisoni RJ, Quiroga E, Bregni C, Chiappetta DA. ()
Farm Hosp -
2010
- ;34:293-7.
molekulid uuritud
(4)
Carvedilol
Clobazam
Glibenclamide
Omeprazole sodium
Mentions Légales
